PROTOCOL FOR VALIDATION OF METHOD OF ANALYSIS FOR CONTAMINATION STUDY OF PARACETAMOL

PROTOCOL FOR VALIDATION OF METHOD OF ANALYSIS FOR CONTAMINATION STUDY OF PARACETAMOL 

Superseded Protocol No. Nil
Effective Date  

Table of contents :

Sr. No. Subject
  Protocol Approval
  Objective
  Scope
  Responsibility of validation team
  Product profile
  Methodology
  Revision History
  1. Protocol Approval:

Prepared By:

Functional Area Name Designation Signature/ Date
Quality Control      

Reviewed By:

Functional Area Name Designation Signature /Date
Quality Assurance      
Head Quality Control      

Approved By:

Functional Area Name Designation Signature /Date
Head QA      

Authorized By:

Functional Area Name Designation Signature /Date
Head Quality      
  • Objective:

The objective of this validation is to validate method of analysis of contamination samples study of Paracetamol by considering the following parameters:

  • Specificity
  • System Precision
  • Linearity
  • Recovery Study
  • Limit of Detection ( LOD )
  • Limit of Quantification ( LOQ )

Following parameters will be seen during system suitability:

Sr. No. Parameters Limit
1. % RSD for peak absorbance of Paracetamol from 6 replicate of standard solution Not more than 2.0

When the above parameters meet the method, the actual experiment shall be started.

  • Scope :

This protocol is based on SOP and applicable for the validation of method of analysis of contamination samples study of Paracetamol.

  • Responsibility of Validation Team:
Departments Responsibilities
QC Preparation & Review of Protocol.
Analysis of samples and recording of data.
Compilation and checking of data
Preparation of Summary Report.
To impart training of protocol to concerned department/persons.
QA Review and approval of protocol.
Co-ordination with QC to carryout Validation.
Review of data and summary report.
Head Quality Authorization of protocol.
  • Product Profile:
Category (% API Content) Analgesic  
Reason for Validation To Validate the analytical method for Cleaning sample analysis.  
Active Ingredient Paracetamol  
Methodology In-House  
Method Reference In-House  
  • Methodology

         Method of analysis:

               Reagents:

  • Methanol
  • Diluents: Methanol
  • Instrument : UV-VIS Spectrophotometer

Standard Solution preparation:

Weigh accurately about 50 mg of Paracetamol working standard in to a 100.0 ml volumetric flask, and add about 50 ml methanol, sonicate to dissolve and dilute to volume with methanol. Further dilute 2.0 ml of this solution to 100.0 ml with methanol.

Determine the maxima in the range of 400 nm to 200 nm by UV-VIS Spectrophotometer using diluents as a blank.

  • Parameters to be Validated:
  • Specificity
  • System Precision
  • Linearity
  • Recovery Study
  • Limit of Detection ( LOD )
  • Limit of Quantification ( LOQ )
  • Specificity:

 Prepare blank, swab blank and standard solution 10 mcg/ml as per procedure given below:

      Standard Solution preparation:

Weigh accurately about 50 mg of Paracetamol working standard in to a 100.0 ml volumetric flask, and add about 50 ml methanol, sonicate to dissolve and dilute to volume with methanol. Further dilute 2.0 ml of this solution to 100.0 ml with methanol.

Blank solution: Diluents

Swab Blank: Take 10.0 ml of diluents in a test tube, dip fresh swab stick in test tube and sonicate for 5 minutes.

Procedure: Take the absorbance ofblank, swab blank and standard solution at maxima in the range of 400 nm to 200 nm.

Acceptance criteria:

There should not be any interference from blank, swab blank with the analyte peak.

  • System Precision:

System precision shall be evaluated bymeasuring the absorbance of 6 replicate of standard solution and calculate the relative standard deviation.

      Standard Solution preparation:

Weigh accurately about 50 mg of Paracetamol working standard in to a 100.0 ml volumetric flask, and add about 50 ml methanol, sonicate to dissolve and dilute to volume with methanol. Further dilute 2.0 ml of this solution to 100.0 ml with methanol.

Acceptance Criteria: % RSD of Six replicate should not be more than 2.0%.

  • Linearity:

The linearity of the method shall be established between 6 mcg/ml to 14 mcg/ml. The sample absorbance shall be plotted against concentration and correlation coefficient shall be calculated.

Minimum five points shall be covered from the range of 6 mcg/ml to 14 mcg/ml.

Following concentrations shall be prepared and analyzed for linearity: 6 mcg/ml, 8mcg/ml, 10 mcg/ml, 12mcg/ml and 14mcg/ml.

Procedure: Measure the absorbance of sample solution in duplicate. Plot the graph of absorbance vs. actual concentration. Calculate the correlation coefficient from linearity curve.

Acceptance Criteria: Correlation coefficient shall not be less than 0.99.

  • Recovery:

Standard Solution preparation:

Weigh accurately about 50 mg of Paracetamol working standard in to a 100.0 ml volumetric flask, and add about 50 ml methanol, sonicate to dissolve and dilute to volume with methanol. Further dilute 2.0 ml of this solution to 100.0 ml with methanol.

Recovery Stock Solution:

Weigh accurately about 50 mg of Paracetamol working standard in to a 100.0 ml volumetric flask, and add about 50 ml methanol, sonicate to dissolve and dilute to volume with methanol.

  1. Spiked the 0.16 ml, 0.20 ml and 0.24 ml of recovery stock solution into the area of 10 x 10 cm2 in three different SS Plates for each concentration.
  2. Allow the solutions to dry in air.
  3. Take the Swab wipe and moisten with diluents, swab one SS plate in the area of 10 x 10 cm2. Collect the swab in the test tube containing already 10.0 ml of   diluents in the test tube and sonicate for 10 minutes with swirling. Squeeze the swab and discard. Filter through 0.45µ filter. Final concentrations of recovery solutions are 8 ppm, 10 ppm, and 12 ppm.
  4. Spike 0.2 ml of recovery stock solution on two more SS plates for 10 ppm recovery. Keep these two spiked plates for 3rd and for 5th day recovery at room temperature. Repeat the procedure to collect the swab sample at 3rd and 5th day. 
  5. Similarly do the recovery on 10× 10 cm2 apron.    

        Acceptance criteria:

        Recovery at each level should not be less than 70%. 

  • Limit of Detection (LOD):

  Limit of detection is the lowest concentration of analyte in a sample that can be detected but not necessarily quantified under the stated experimental condition.

  Based on the standard deviation of the response of swab blank and the slope of linearity curve, LOD shall be calculated by the following equation:

                                    LOD (mcg/ml)     =     3.3 x σ

                                                                           S

  Where σ = Standard deviation of the response of swab blank.

              S = Slope of Linearity Curve.

  • Verification of Limit of Detection (LOD):

   Prepare the LOD Sample and measure the absorbance of LOD sample in six replicates. Calculate % RSD for six replicates of Paracetamol.

       Acceptance criteria:

% RSD for six replicates shall be not more than 30.

  • Limit of Quantification (LOQ):

 Limit of Quantification is the lowest concentration of analyte in a sample that can be quantify with   acceptable precision under the stated experimental condition.

 Based on the standard deviation of the response of swab blank and the slope of linearity curve, LOQ shall be calculated by the following equation:

                                    LOD (mcg/ml)     =       10 x σ

                                                                           S

  Where σ = Standard deviation of the response of swab blank.

                    S = Slope of Linearity Curve.

  • Verification of Limit of Quantification (LOQ):

Prepare the LOQ Solution and measure the absorbance of sample in six replicates. Calculate %  RSD for six replicates of Paracetamol.

      Acceptance criteria:

% RSD for six replicates shall be not more than 10.

  • Revision History:
Revision No. Details of changes Reason  
00 Nil New  

Bhanu Pratap Singh

BHANU PRATAP SINGH IS EXPERIENCED IN PHARMACEUTICAL, AUTHOR AND FOUNDER OF PHARMACEUTICAL GUIDESLINE (WWW.PHARMAGUIDESLINE.COM), A WIDELY READ PHARMACEUTICAL BLOG SINCE 2019. EMAIL:- INFO@PHARMAGUIDESLINE.COM

View all posts by Bhanu Pratap Singh →

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!